Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05052541 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy of Oral Cannabis in Chronic Spine Pain
A Phase 3 study of Back Pain and Neck Pain, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 157
- Enrollment target
- 1
- Study location
NCT05052541 is a Phase 3 study of Back Pain and Neck Pain that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 157 participants, above the 138-participant average among 37 other Back Pain trials with a reported enrollment target (14% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05052541, a Phase 3 study of Back Pain and Neck Pain, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 157 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall objectives of this study are to investigate the efficacy of extended cannabis treatment to reduce patient exposure to prescription opioids through its use 1) as a non-opioid analgesic treatment, and 2) as a therapy for reducing high-dose opioid use in patients with chronic spine pain.
Interventions
- DRUG Placebo
- DRUG THC/CBD
- DRUG THC
Study Locations (1)
Colorado
- University of Colorado Anschutz Medical Campus - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 157 participants |
| Start Date | 2026-01 |
| Est. Completion | 2027-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05052541
The ClinicalTrials.gov registry entry for NCT05052541 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 157 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 138-participant average among 37 other Back Pain trials with a reported enrollment target (14% higher). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Back Pain appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT05052541 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT05052541 about?
NCT05052541 is a clinical study titled "Safety and Efficacy of Oral Cannabis in Chronic Spine Pain". The overall objectives of this study are to investigate the efficacy of extended cannabis treatment to reduce patient exposure to prescription opioids through its use 1) as a non-opioid analgesic treatment, and 2) as a therapy for reducing high-dose opioid use in patients with chronic spine pain.
What is the current status of trial NCT05052541?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 157 participants. The study started on 2026-01. Estimated completion is 2027-06.
What conditions does trial NCT05052541 study?
This clinical trial studies the following conditions: Back Pain, Neck Pain.
What interventions are being tested in trial NCT05052541?
The interventions under investigation include: Placebo (DRUG), THC/CBD (DRUG), THC (DRUG).
Who is sponsoring clinical trial NCT05052541?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05052541 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Back Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CARES-Spine (Comprehensive Analgesic, Recovery, and Education Support for Spine Surgery) Trial
RECRUITING · Phase 3
-
An Implantable Spinal Cord Stimulation Pain Management System
COMPLETED · Phase 3
-
Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis
COMPLETED · Phase 3
-
Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers Mixed With Autograft in Patients Undergoing Posterolateral Lumbar Fusion
RECRUITING · NA
-
Dose Escalation Pilot Study to Evaluate the Safety of Alocyte for the Treatment of Facetogenic Back Pain
RECRUITING · Phase 1
-
Cannabidiol for Reduction of Brain Neuroinflammation
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.